Partner Headlines - IBB

  1. Illumina Brings More Pain To Battered Biotech ETFs; Gold Hits ...

    IBD
  2. TickerTags Data Shows Drug Price Debate Still Trending

    Benzinga
  3. Even With Volatility, Investors Love Biotech ETFs

    Benzinga
  4. Equal Weighting Works For This Industry ETF

    Benzinga
  5. Biotechs Sell Off Hard, But Indexes Cut Their Losses

    IBD
  6. Biotech ETFs: Buy, Buy, Buy?

    Benzinga
  7. Social Media Beat: What Experts And The Crowd Think Of Biotechs, ...

    Benzinga
  8. Biotech Bears Spark Good Vibes For These ETFs

    Benzinga
  9. Techs Erase Early Gains; Apple, Facebook Lead Nasdaq 100 Lower

    IBD
  10. Small-Cap Healthcare ETF: A Baby Thrown Out With The Bathwater

    Benzinga
  11. The Weak Get Weaker In The Options Market

    Benzinga
  12. Fast Money Picks For September 22

    Benzinga
  13. This Week In Options: Where Is The Rally?

    Benzinga
  14. Why Biotech & Healthcare Are The Biggest Risks To The Market

    Benzinga
  15. The Other Bearish Biotech ETF Is Looking Groovy, Too

    Benzinga
  16. IBB Holding Early Morning Lows

    Benzinga
  17. Fast Money Picks For August 18

    Benzinga
  18. This Week's ETF's To Watch: A Lot Of Familiar Faces

    Benzinga
  19. A Bad Week For Biotech Was Great For This ETF

    Benzinga
  20. China, Greece Don't Derail ETF Inflows In July

    Benzinga
  21. Even With Recent Declines, Investors Still Love Biotech ETFs

    Benzinga
  22. These 4 Foreign Drug Stocks Have Broken Out Recently

    IBD
  23. Caution Continues In Options Market This Week

    Benzinga
  24. A Big Day For Biotech And It's Not Going So Well

    Benzinga
  25. A Look Ahead: Biotech And Energy ETFs To Watch This Week

    Benzinga
  26. Vista Partners Initiates Coverage on Immune Pharmaceuticals Inc. ...

    GuruFocus
  27. As Biotech Beats, 6 Top ETF Picks For Rest Of 2015

    IBD
  28. ProShares Releases 2 New Leveraged Biotech ETFs

    Benzinga
  29. Biotech ETFs Hit New 2015 Highs

    Benzinga
  30. Investment Strategies for the Bullish Biotech Sector

    GuruFocus
  31. 'Don't Give Up On Biotech Yet,' Says This CFA

    Benzinga
  32. Making Money With Charles Payne: 05/1/15

    FoxBusiness
  33. Nasdaq Leads Market Lower As Medical Stocks Tumble

    IBD
  34. Technology, Inflation Protection And Biotech ETFs To Watch This ...

    Benzinga
  35. How To Invest In ETFs: Tips To Trade Top Market Trends

    IBD
  36. Social Media Analytics: 3 ETFs Recently Blowing Up On Twitter

    Benzinga
  37. The Best Biotech ETF Isn't Always The Biggest

    Benzinga
  38. Biotech Stocks Moving Higher

    Benzinga
  39. Evercore ISI Technical Analysis: The 'Single Best Idea'

    Benzinga
  40. Top 5 Biotech Stocks That The Smart Money Doesn't Like

    Benzinga
  41. iShares NASDAQ Biotech ETF Pulls Back Off All-Time Highs

    Benzinga
  42. Making Money With Charles Payne: 01/14/15

    FoxBusiness
  43. Are There Any Winners Left In The Biotech Space?

    Benzinga
  44. Biotech Stocks Sell Off, ETFs Fall Over 5%

    Benzinga
  45. Making Money With Charles Payne: 12/22/14

    FoxBusiness
  46. 3 Biotech ETFs Rally On Merger News

    Benzinga
  47. A Look At 3 Overbought ETFs

    Benzinga
  48. 1 Biotech Beast Worth Tracking

    Benzinga
  49. Best And Worst ETFs Of The Week Amid Biotech Breakout

    Benzinga
  50. Arrowhead Research Corp Heads Higher After Breakout

    Benzinga
  51. Biotechnology, Oil And Brazil ETFs To Watch This Week

    Benzinga
  52. Isis Pharmaceuticals Finally Breaks Out

    Benzinga
  53. Yellen Says Social Media, Biotech Stocks 'Substantially Stretched'

    Benzinga
  54. 4 ETFs With Upside Potential

    Benzinga
  55. Dow Closes At A New High As Late-Month Rally Boosts Stocks

    Benzinga
  56. Johnson & Johnson: Why Top Funds Are Buying

    YCharts
  57. Stocks Revisit Session Lows; Share Offer Lifts GasLog

    IBD
  58. Don't Panic Over Recent Tech Turmoil

    FoxBusiness
  59. Despite S&P 500's New High, Stocks Face Challenges

    Benzinga
  60. Biotech ETFs Come Back Down To Earth

    Benzinga
  61. ETF Outlook For Wednesday, March 26, 2014 (IBB, IPO, FPX, SOCL, ...

    Benzinga
  62. ETF Outlook For The Week Of March 24, 2014 (IBB, CARZ, RSX, GM)

    Benzinga
  63. Stocks Edge Lower In Dull Session; Biogen Idec Hangs Tough

    IBD
  64. Biotech ETFs Flash Buy Signals (XBI, IBB, BBH, ICPT)

    Benzinga
  65. Biotech And Natural Gas ETFs On A Roll

    Benzinga
  66. ETF Outlook For The Week Of February 10 (IBB, VXZ, GREK, GDX)

    Benzinga
  67. Sector ETFs Breaking Out (IBB, IHE, XLV, IAT, SKYY)

    Benzinga
  68. ETF Outlook for Friday, December 20 (REM, USO, IBB, FCG)

    Benzinga
  69. The One True Sector Bubble: Profits Here When It Crashes Soon

    Benzinga
  70. ETF Outlook for Tuesday, November 26, 2013

    Benzinga
  71. Biotech ETFs Plummeting (XBI, IBB, BBH)

    Benzinga
  72. Biotech Breakout Highlights Flawed ETF Thinking

    Benzinga
  73. Three Soaring, But Overlooked Health Care ETFs

    Benzinga
  74. Seasonal Trends: Three ETFs To Own In August

    Benzinga
  75. Three ETFs That Have Blown Past Their 200-Day Lines

    Benzinga
  76. ETFs to Watch July 29, 2013 (BOND, EWJ, IBB)

    Benzinga
  77. Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)

    Benzinga
  78. Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)

    Benzinga
  79. Use The Sharpe Ratio For Profits With These ETFs

    Benzinga
  80. 4 Health Care ETFs Your Broker Forgot to Mention

    Benzinga
  81. Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)

    Benzinga
  82. These ETFs Are Awash in 2013 Takeover Targets

    Benzinga
  83. Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX)

    Benzinga
  84. Short Interest Swings in Biotech Stocks (BIIB, GILD, VVUS)

    Benzinga
  85. S&P Likes a Trio of Biotech ETFs

    Benzinga
  86. ETFs to Watch October 23, 2012 (FCF, IBB, EWT)

    Benzinga
  87. Investors Cheating Themselves by Focusing on Largest ETFs

    Benzinga
  88. Three Biotech Stocks Analysts Are Keen On (ARIA, MACK, GEVA)

    Benzinga
  89. When Cheaper Is Better With ETFs

    Benzinga
  90. Possible Hepatitis C Outbreak Could Lift This ETF

    Benzinga
  91. Low Volume, High Returns for These ETFs (BIB, FHC, DRW)

    Benzinga
  92. Small-Cap Corner: A Forgotten Biotech ETF

    Benzinga
  93. ETFs to Watch July 3, 2012 (TNA, XLB, PCY)

    Benzinga
  94. Arena Approval Boosts Biotech ETFs (ARNA, IBB, XBI)

    Benzinga
  95. The Definitive Biotech ETF Guide (IBB, XBI, FBT)

    Benzinga
  96. 4 High P/E ETFs (IBB, IGV, PNQI)

    Benzinga
  97. S&P Bullish On Biotech ETFs (FBT, IBB, XBI)

    Benzinga
  98. 4 Ignored ETFs Up More Than 20% YTD (GERJ, VROM, TAO)

    Benzinga
  99. Viva Vivus, But Not In ETFs (VVUS, IBB, PJP)

    Benzinga
  100. 10 ETFs That Should Lower Their Expense Ratios

    Benzinga
Trading Center